US patent for Marina Biotech's fundamental RNAi delivery
Marina Biotech, Inc., a leading RNAi-based drug discovery and development company, announced that the US Patent and Trademark Office has issued a Notice of Allowance for patent application US 11/745,003 broadly covering amphoteric liposomal formulations, including the company's proprietary Smarticles technology, for delivery of siRNAs and other compounds with therapeutic application.
Prolor Biotech gets US FDA clearance for phase II trial of its long-acting human growth hormone in US
Prolor Biotech, Inc., a company developing next generation biobetter therapeutic proteins, announced that it has received regulatory clearance from the US Food and Drug Administration (FDA) to conduct a phase II clinical trial in the US of its longer-acting version of human growth hormone, hGH-CTP.
Niusule Biotech Corporation to Present at the Rodman & Renshaw 2010 Annual Global Investment Conference
MONROVIA, CA--(Marketwire - August 30, 2010) - Niusule Biotech Corp. ( OTCBB : NIUS ) (the Company) , a fast growing China-based bio-pharmaceutical company focusing on animal-health products and human nutraceutical supplements, today announced they will present at the Rodman & Renshaw 2010 Annual Global Investment Conference. The conference will be held September 12-15, 2010, at The New York ...
Marina Biotech Announces Allowance of Fundamental RNAi Delivery Patent From U.S. Patent Office
BOTHELL, WA--(Marketwire - 08/30/10) - Marina Biotech, Inc. (NASDAQ: MRNA - News ), a leading RNAi-based drug discovery and development company, today announced that the U.S. Patent and Trademark Office has issued a Notice of Allowance for patent application U.S. 11/745,003 broadly covering amphoteric liposomal formulations, including the Company's proprietary SMARTICLES technology, for delivery ...
Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw Annual Global Investment Conference
XI'AN, CHINA--(Marketwire - September 1, 2010) - Skystar Bio-Pharmaceutical Company ( NASDAQ : SKBI ) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on ...
Skystar Bio-Pharmaceutical to Present at Rodman & Renshaw Annual Global Investment Conference
XI'AN, CHINA--(Marketwire - 09/01/10) - Skystar Bio-Pharmaceutical Company (NASDAQ: SKBI - News ) ("Skystar" or the "Company"), a China-based manufacturer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that the Company will present at the Rodman & Renshaw Annual Global Investment Conference at The Palace Hotel in New York City on September ...
